Longeveron Inc share price logo

Longeveron Inc Share Price

NASDAQ: LGVN

Small Cap

$0.88

-0.09

(-9.59%)

as on

Longeveron Inc Stock Performance

as on March 17, 2026 at 6:59 am IST

  • Day's High

    $0.88
    $1.22

    38.64%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.48
    $1.92
    downward going graph

    46.02%

    Downside

    118.16%

    Upside

    downward going graph

Longeveron Inc share price movements today

Previous Close
$0.97
Open
$1.08
Volume
21.4M
Day's Low - High
$0.88 - $1.22
52 Week Low - High
$0.48 - $1.92

Longeveron Inc Historical Returns

1 Month Return
+ 81.69 %
3 Month Return
+ 76.1 %
1 Year Return
-42.4 %
3 Year Return
-96.61 %
5 Year Return
-98.68 %

Longeveron Inc Stock Fundamentals & Key Indicators

Check Longeveron Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.7M

EPS (TTM)

-1.1875

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.96

Industry PE ratio

0

PEG Ratio

0

EBITDA

-21.0M

Revenue (TTM)

1.4M

Profit Margin

0.00%

Return On Equity TTM

-119.92%

Longeveron Inc Stock Valuation

Track how Longeveron Inc P/E has moved over time to understand its valuation trends.

Longeveron Inc in the last 5 years

  • Overview

  • Trends

Lowest (-119.39x)

December 31, 2021

Industry (0.00x)

March 16, 2026

Today (-0.96x)

March 16, 2026

Highest (-0.44x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.96x

Longeveron Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Longeveron Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Longeveron Inc image
Longeveron Inc
BUY$14.7M-98.68%-0.960.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.6B117.98%135.098.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$119.2B114.32%30.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.8BNA1155.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.8B54.67%17.9931.41%

Stock Returns calculator for Longeveron Inc Stock including INR - Dollar returns

The Longeveron Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Longeveron Inc investment value today

Current value as on today

₹58,570

Returns

₹41,430

(-41.43%)

Returns from Longeveron Inc Stock

₹47,929 (-47.93%)

Dollar Returns*

₹6,499 (+6.5%)

Analyst Recommendation on Longeveron Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Longeveron Inc. Average target price of $6.86

Longeveron Inc Share Price Target

Get share price movements and forecasts by analysts on Longeveron Inc.

What analysts predicted

87.17%UPSIDE

Target Price

$6.86

Current Price

$0.88

Analyzed by

8 Analysts

Target

$6.86

Longeveron Inc target price $6.86, a slight upside of 87.17% compared to current price of $0.88. According to 8 analysts rating.

Longeveron Inc Stock’s Investor Sentiment and Interest

Search interest for Longeveron Inc Stock has increased by 2394% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2394% versus previous 30 day period

Longeveron Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-5
-5
-5
-4
-3
-4
-4
-5
-5
-7
EBITDA
-5
-4
-5
-3
-3
-4
-4
-4
-4
-6
Interest Expense
-
-
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-5
-6
-4
-3
-4
-4
-5
-5
-7
Income Tax Expense
0
0
0
0
-
-
-
-
-
-
Net Income
-5
-5
-6
-4
-3
-4
-4
-5
-5
-7
Net Profit Margin
-2595.39%
-3404.00%
-9568.25%
-740.51%
-729.27%
-571.67%
-676.78%
-1315.22%
-1591.14%
-5270.80%

Longeveron Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
2
5
5
1
1
0
2
Gross Profit
0
1
1
0
0
0
1
Operating Income
-6
-3
-3
-17
-18
-21
-16
EBITDA
-5
-2
-2
-16
-17
-20
-15
Interest Expense
-
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-6
-3
-3
-17
-18
-21
-15
Income Tax Expense
0
0
0
0
0
0
-24
Net Income
-6
-3
-3
-17
-18
-21
-15
Net Profit Margin
-296.84%
-66.09%
-66.10%
-1305.13%
-1541.33%
-3020.17%
-667.77%

Longeveron Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-5
-6
-4
-3
-4
-4
-5
-5
-7
Operating Cash Flow
-4
-3
-3
-4
-2
-3
-4
-3
-5
Investing Cash Flow
3
1
0
0
0
0
0
0
0
Financing Cash Flow
0
5
0
15
13
0
0
0
4
Change in Cash
0
2
-3
10
10
-3
-4
-3
-1

Longeveron Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-3
-17
-18
-21
-15
Operating Cash Flow
-2
-2
-9
-13
-19
-13
Investing Cash Flow
0
0
-10
0
8
0
Financing Cash Flow
0
1
45
0
5
28
Change in Cash
-2
-1
24
-15
-5
14

Global Institutional Holdings in Longeveron Inc

Funds
Holdings
UBS Group AG
0.42%
Steward Partners Investment Advisory, LLC
0.02%
Moneta Group Investment Advisors Inc
0.14%
Susquehanna International Group, LLP
0.09%
Lido Advisors, LLC
0.07%
See all

Insights on Longeveron Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LGVN stock has moved up by 83.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 65.2% return, outperforming this stock by 161.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.6% return, outperforming this stock by 72.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 5 quarters, 773.0K → 137.0K (in $), with an average decrease of 33.1% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, -4.08M → -7.22M (in $), with an average decrease of 22.3% per quarter

About Longeveron Inc

longeveron llc is a leading global regenerative medicine company developing innovative cellular therapeutics for chronic life-threatening diseases. our lead investigational product candidate (lmsc) is based on a specialized cell known as a mesenchymal stem cell that is derived from the bone marrow of healthy young adult donors. our allogeneic, ‘off-the-shelf’ product is under investigation for chronic conditions of the elderly, and other life- threatening diseases, for which no approved therapeutics currently exist: • aging frailty syndrome • alzheimer’s disease • hypoplastic left heart syndrome • the metabolic syndrome
OrganisationLongeveron Inc
HeadquartersLife Science & Technology Park, Miami, FL, United States, 33136
CEOMr. Stephen H. Willard Esq.
E-voting on sharesClick here to vote

Key Management of Longeveron Inc

Name

Title

Ms. Jen Dumas

Vice President of Human Resources

Dr. Nataliya Agafonova M.D.

Chief Medical Officer

Ms. Lisa McClain-Moss

Vice President of Manufacturing

Mr. Brian G Rash Ph.D.

VP of Research & Discovery

Dr. Joshua Michael Hare FACC, M.D.

Co-Founder, Chief Science Officer & Executive Chairman

Mr. Stephen H. Willard Esq.

Chief Executive Officer

Mr. Devin Blass

CTO & Senior VP of Chemistry, Manufacturing, and Controls

Ms. Heather Zhou

VP & Corporate Controller

Ms. Lisa A. Locklear M.B.A.

CFO, Executive VP & Treasurer

Mr. Paul T. Lehr J.D.

General Counsel & Secretary

FAQs

What is Longeveron Inc share price today?

Longeveron Inc share price today is $0.88 as on at the close of the market. Longeveron Inc share today touched a day high of $1.22 and a low of $0.88.

What is the 52 week high and 52 week low for Longeveron Inc share?

Longeveron Inc share touched a 52 week high of $1.92 on and a 52 week low of $0.48 on . Longeveron Inc stock price today i.e. is closed at $0.88,which is 54.16% down from its 52 week high and 85.26% up from its 52 week low.

What is Longeveron Inc's market capitalisation today?

Longeveron Inc market capitalisation is $0.00T as on .

How to invest in Longeveron Inc Stock (LGVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Longeveron Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Longeveron Inc Shares that will get you 1.7045 shares as per Longeveron Inc share price of $0.88 per share as on March 17, 2026 at 1:29 am IST.

What is the minimum amount required to buy Longeveron Inc Stock (LGVN) from India?

Indian investors can start investing in Longeveron Inc (LGVN) shares with as little as ₹92.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹923.35 in Longeveron Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Longeveron Inc share’s latest price of $0.88 as on March 17, 2026 at 1:29 am IST, you will get 11.3636 shares of Longeveron Inc. Learn more about fractional shares .

What are the returns that Longeveron Inc has given to Indian investors in the last 5 years?

Longeveron Inc stock has given -98.68% share price returns and 27.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?